Study on Cardiac Output Evaluation Based on Wearable Monitoring Data
Launched by NAVY GENERAL HOSPITAL, BEIJING · Apr 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how wearable devices, like smartwatches or fitness bands, can help measure cardiac output, which is a key indicator of heart function. The goal is to create a new way to assess how well the heart is working without needing invasive procedures. Researchers want to see if they can improve how these devices detect heart capacity during times of rest and exercise.
To participate in this study, you need to be over 18 years old and have a specific heart condition where your heart's ability to pump blood is affected (either with a lower or normal ejection fraction). You should also be comfortable using a smartphone and wearable technology. However, if you have a pacemaker, are pregnant or breastfeeding, or have certain health issues that prevent you from exercising, you may not be eligible. Participants can expect to help advance heart health monitoring while using wearable devices, but the trial is not yet recruiting, so no one can join at this moment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years old
- • Left ventricular ejection fraction (Left ventricular ejection fraction, LVEF) \< 50%(200 subjects)
- • Left ventricular ejection fraction (Left ventricular ejection fraction, LVEF) ≥50% (100 subjects)
- • Able to use smart phones and operate wearable devices such as wristbands/watches
- Exclusion Criteria:
- • Patients with pacemaker implantation
- • No smartphone
- • Currently participating in other clinical trials
- • Lactating women
- • Pregnant Women
- • Unable to run and ride due to personal physical and external reasons (subjects participating in the exercise state cardiac output model study)
- • Physical examination results in the past year have clear cardiovascular, metabolic, bone and joint related diseases that have exercise risk, or have diseases and related potential health risks confirmed by the self-examination form of physical status before exercise (participants in the exercise state cardiac output model study)
- • No informed consent was obtained
About Navy General Hospital, Beijing
Navy General Hospital in Beijing is a prominent medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a leading sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, aiming to enhance patient outcomes and contribute to medical knowledge. With a robust infrastructure, a team of experienced researchers, and a commitment to ethical standards, Navy General Hospital fosters collaborations with various stakeholders to ensure the successful execution of clinical trials that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported